Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs
About Pharma Equity Group A/S
About Pharma Equity Group A/S
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.